The role of hydroxychloroquine in managing interstitial lung disease (ILD) associated with autoimmune conditions illustrates its potential in pulmonary medicine. By reducing inflammation and fibrosis,
hydroxychloroquine sulfate 200mg could help preserve lung function and improve quality of life for patients with autoimmune-related ILD, underscoring the importance of exploring its therapeutic effects in respiratory conditions.